Famotidine 25021-0756-50
- Manufacturer
- Sagent Pharmaceuticals
- Dosage Form
- Injection, Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- October 15, 2025
- Listing Expires
- December 31, 2026
- Application
- NDA219935
Need to source Famotidine? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Famotidine | 4 mg/mL |
Drug Class
Histamine-2 Receptor Antagonist [EPC]Histamine H2 Receptor Antagonists [MoA]Histamine-2 Receptor Antagonist [EPC]
Selected Package
25021-0756-50Selected1 VIAL in 1 CARTON (25021-756-50) / 50 mL in 1 VIAL
Other packages for this product(1)
10 VIAL in 1 CARTON (25021-756-10) / 10 mL in 1 VIAL